ATE374463T1 - Verfahren zur herstellung von oxazolidinonen - Google Patents

Verfahren zur herstellung von oxazolidinonen

Info

Publication number
ATE374463T1
ATE374463T1 AT02725224T AT02725224T ATE374463T1 AT E374463 T1 ATE374463 T1 AT E374463T1 AT 02725224 T AT02725224 T AT 02725224T AT 02725224 T AT02725224 T AT 02725224T AT E374463 T1 ATE374463 T1 AT E374463T1
Authority
AT
Austria
Prior art keywords
oxazolidinones
producing
producing oxazolidinones
Prior art date
Application number
AT02725224T
Other languages
English (en)
Inventor
William Perrault
Bruce Pearlman
Delara Godrej
Original Assignee
Pharmacia & Upjohn Co Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26963272&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE374463(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Pharmacia & Upjohn Co Llc filed Critical Pharmacia & Upjohn Co Llc
Application granted granted Critical
Publication of ATE374463T1 publication Critical patent/ATE374463T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D263/16—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D263/18—Oxygen atoms
    • C07D263/20—Oxygen atoms attached in position 2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/16—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms
    • C07C233/17—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom
    • C07C233/18—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom having the carbon atom of the carboxamide group bound to a hydrogen atom or to a carbon atom of an acyclic saturated carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
AT02725224T 2001-04-20 2002-04-15 Verfahren zur herstellung von oxazolidinonen ATE374463T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US28558601P 2001-04-20 2001-04-20
US36558102P 2002-03-19 2002-03-19

Publications (1)

Publication Number Publication Date
ATE374463T1 true ATE374463T1 (de) 2007-10-15

Family

ID=26963272

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02725224T ATE374463T1 (de) 2001-04-20 2002-04-15 Verfahren zur herstellung von oxazolidinonen

Country Status (18)

Country Link
US (2) US6887995B2 (de)
EP (1) EP1380121B1 (de)
JP (1) JP2005504007A (de)
AR (1) AR035830A1 (de)
AT (1) ATE374463T1 (de)
AU (1) AU2002255803B2 (de)
CA (1) CA2440600A1 (de)
CY (1) CY1107003T1 (de)
DE (1) DE60222645T2 (de)
DK (1) DK1380121T3 (de)
ES (1) ES2291465T3 (de)
MX (1) MXPA03009645A (de)
MY (1) MY129372A (de)
NZ (1) NZ528996A (de)
PE (1) PE20021057A1 (de)
PT (1) PT1380121E (de)
TW (1) TWI252229B (de)
WO (1) WO2002085849A2 (de)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2535796A1 (en) * 2003-08-22 2005-03-03 Pharmacia & Upjohn Company Llc N-aryl-2-cyanooxazolidinones and their derivatives
ES2331454T1 (es) * 2003-10-16 2010-01-05 Symed Labs Limited Forma cristalina de linezolid.
US7186844B2 (en) * 2004-01-13 2007-03-06 Mitsubishi Gas Chemical Co., Inc. Method for producing cyclic carbamate ester
CN100369909C (zh) * 2004-03-23 2008-02-20 中国科学院上海药物研究所 N-[4（r）－（1，3－二噁烷基）甲基]苯胺、制备方法和用途
ES2294494T3 (es) 2004-04-19 2008-04-01 Symed Labs Limited Un nuevo procedimiento para la preparacion de linezolid y compuestos relacionados.
AU2006231919A1 (en) 2005-04-06 2006-10-12 Pharmacia & Upjohn Company Llc 7-fluoro-1,3-dihydro-indol-2-one oxazolidinones as antibacterial agents
EP2033960A3 (de) * 2007-09-04 2009-04-29 Dipharma Francis S.r.l. Kristalline Linezolidhydratform und Linezolidsalze
ITMI20072359A1 (it) * 2007-12-18 2009-06-19 Dipharma Francis Srl Procedimento per la preparazione di derivati ossazolidinonici
EP2163547A1 (de) 2008-09-16 2010-03-17 Unión Químico Farmacéutica, S.A. (UQUIFA) Verfahren für die Herstellung eines antibakteriellen Oxazolidinon-Wirkstoffs und Zwischenprodukte davon
CA2785620A1 (en) 2009-12-26 2011-06-30 Alembic Pharmaceuticals Limited Process for the preparation of linezolid
JP2014500247A (ja) 2010-11-03 2014-01-09 ウォックハート リミテッド リン酸モノ−（１−｛４−［（ｓ）―５−（アセチルアミノメチル）−２−オキソ−オキサゾリジン−３−イル］−２，６−ジフルオロフェニル｝−４−メトキシメチルピペリジン−４−イル）エステルの調製方法
CN102731336B (zh) 2011-04-12 2014-05-07 浙江医药股份有限公司新昌制药厂 利奈唑胺中间体及合成利奈唑胺的方法
CN102267955A (zh) * 2011-06-02 2011-12-07 山东鲁抗医药股份有限公司 一种利奈唑胺的制备方法
CN103130733B (zh) * 2011-12-02 2015-07-01 重庆圣华曦药业股份有限公司 制备利奈唑胺的方法
CN102516191B (zh) * 2011-12-21 2014-03-26 吉林省博大伟业制药有限公司 一种利奈唑胺的制备方法
CN102977056B (zh) * 2012-11-28 2014-11-26 深圳万乐药业有限公司 N-苄氧羰基-3-氟-4-吗啉基苯胺的合成方法
CN104140399A (zh) * 2013-05-08 2014-11-12 江苏豪森药业股份有限公司 利奈唑胺的制备方法
CN103483294B (zh) * 2013-08-12 2015-01-28 四川大学 3-氨基-2-丙醇乙酰胺类化合物的盐、其制备方法和用途
WO2015173664A1 (en) 2014-05-14 2015-11-19 Wockhardt Limited Process for the preparation of (5s)-n-{3-[3,5-difluoro-4-(4-hydroxy-4-methoxymethyl-piperidin-1-yl)-phenyl]-2-oxo-oxazolidin-5-ylmethyl}-acetamide
CN105111160B (zh) * 2015-09-11 2017-04-12 浙江新东港药业股份有限公司 一种利奈唑胺的制备方法
US20170217911A1 (en) * 2015-12-18 2017-08-03 Mankind Research Centre Process For Preparation Of Linezolid
CN111077248A (zh) * 2019-12-24 2020-04-28 江苏乾元生物科技有限公司 Uplc-ms/ms检测(s)-1-氨基-3-氯-2-丙醇盐酸盐的方法
CN115219632B (zh) * 2022-07-29 2024-04-05 山东达因海洋生物制药股份有限公司 一种(s)-1-氨基-3-氯-2-丙醇盐酸盐的hplc-elsd检测方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5688792A (en) 1994-08-16 1997-11-18 Pharmacia & Upjohn Company Substituted oxazine and thiazine oxazolidinone antimicrobials
ES2193201T3 (es) 1994-11-15 2003-11-01 Upjohn Co Agentes antibacterianos tipo oxazolidonas sustituidas con oxazina y tiazina biciclica.
DE69616366T2 (de) 1995-09-01 2002-07-04 Upjohn Co Phenyloxazolidinone mit einer c-c-bindung zu 4-8 gliedrigen heterocyclen
MX9703040A (es) 1995-09-12 1997-07-31 Upjohn Co Antimicrobianos de feniloxazolidinona.
EP0892792B1 (de) 1996-04-11 2001-11-21 PHARMACIA & UPJOHN COMPANY Verfahren zur herstellung von oxazolidinonen
PT1028940E (pt) * 1997-11-07 2007-06-25 Pharmacia & Upjohn Co Llc Processo para produzir oxazolidinonas
PE20020044A1 (es) * 2000-06-16 2002-01-30 Upjohn Co Tiazina oxazolidinona

Also Published As

Publication number Publication date
PT1380121E (pt) 2007-11-21
MY129372A (en) 2007-03-30
EP1380121B1 (de) 2007-09-26
DK1380121T3 (da) 2007-12-27
AR035830A1 (es) 2004-07-14
TWI252229B (en) 2006-04-01
US20040220407A1 (en) 2004-11-04
DE60222645T2 (de) 2008-07-17
JP2005504007A (ja) 2005-02-10
WO2002085849A3 (en) 2003-03-06
ES2291465T3 (es) 2008-03-01
WO2002085849A2 (en) 2002-10-31
US7087784B2 (en) 2006-08-08
CA2440600A1 (en) 2002-10-31
DE60222645D1 (de) 2007-11-08
NZ528996A (en) 2006-01-27
CY1107003T1 (el) 2012-09-26
US20020169312A1 (en) 2002-11-14
AU2002255803B2 (en) 2008-07-03
US6887995B2 (en) 2005-05-03
MXPA03009645A (es) 2004-01-29
PE20021057A1 (es) 2002-11-27
EP1380121A2 (de) 2004-01-14

Similar Documents

Publication Publication Date Title
DE60221399D1 (de) Verfahren zur herstellung von mitteldistillaten
ATE403641T1 (de) Verfahren zur herstellung von o- desmethylvenlafaxin
ATE468309T1 (de) Verfahren zur herstellung von olefinen
DE50107437D1 (de) Verfahren zur herstellung von polyacrylaten
ATE374463T1 (de) Verfahren zur herstellung von oxazolidinonen
AT7110U9 (de) Verfahren zur herstellung von amlodipinmaleat
DE60230908D1 (de) Verfahren zur herstellung von polyarylenethern
ATE453648T1 (de) Verfahren zur herstellung von hexahydrofuroc2,3- büfuran-3-ol
DE60109101D1 (de) Verfahren zur Herstellung von Zahnnuten
ATE286011T1 (de) Verfahren zur herstellung von 1-octen
DE60327788D1 (de) Verfahren zur herstellung von polytrimethylenterephthalt-fasern
ATE315099T1 (de) Verfahren zur herstellung von tagatose
DE60126336D1 (de) Verfahren zur herstellung von hochreinen durchscheinenden perfluorelastomer-gegenständen
DE60200836D1 (de) Verfahren zur herstellung von kunststoffteilanordnungen
ATE296287T1 (de) Verfahren zur herstellung von repaglinide
DE50102444D1 (de) Verfahren zur herstellung von isocyanatoorganosilanen
ATE506351T1 (de) Verfahren zur herstellung von 10,11-dihydro-10- oxo-5h-dibenzoäb,füazepin-5-carboxamid
ATE316518T1 (de) Verfahren zur herstellung von (r)-2-alkyl-3- phenyl-1-propanolen
DE60236754D1 (de) Verfahren zur herstellung von polyoxyalkylenpolyetherprodukten
ATE441662T1 (de) Verfahren zur herstellung von echinocandinderivaten
DE50111560D1 (de) Verfahren zur herstellung von guerbetalkoholen
ATE360610T1 (de) Verfahren zur herstellung von cilastatin
ATE553103T1 (de) Verfahren zur herstellung von (s)-pantoprazol
DE60210911D1 (de) Verfahren zur Herstellung von dehnungserfassenden Vorrichtungen
DE60103173D1 (de) Verfahren zur herstellung von 3-amino-2-chlor-4-methylpyridin

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1380121

Country of ref document: EP

REN Ceased due to non-payment of the annual fee